Table 1

Associations between CPM and CPSF6 polymorphisms and silicosis risk

GeneSNPPositionLocationAlleles*Cases†Controls†MAF‡OR (95% CI)§P value¶
=177=204(case/control)
CPM rs731321269,356,027IntronA/G146/29/1179/20/50.09/0.071.22 (0.70 to 2.15)0.482
rs1281250069,357,2310.21 kb upstreamC/G70/81/2597/86/210.37/0.311.45 (1.03 to 2.04)0.034
rs798067369,360,0293.01 kb upstreamG/A136/39/1143/56/50.12/0.160.65 (0.40 to 1.06)0.087
rs190866869,360,7343.71 kb upstreamT/C155/21/0182/21/10.06/0.061.29 (0.64 to 2.59)0.480
CPSF6 rs1183811269,629,0334.28 kb upstreamT/C101/64/12105/82/170.25/0.280.84 (0.58 to 1.21)0.338
rs1117756669,630,9112.41 kb upstreamC/A105/66/6125/67/120.22/0.221.10 (0.74 to 1.63)0.639
rs1117756869,634,143IntronC/T155/21/1174/30/00.06/0.071.10 (0.57 to 2.10)0.784
rs230564169,646,914ExonC/T57/82/3875/89/400.45/0.411.07 (0.78 to 1.47)0.678
  • *Major/minor allele.

  • †Wild-type homozygote/heterozygote/variant homozygote.

  • ‡MAF between cases and controls.

  • §Logistic regression analysis adjusted for age, gender, years of silica dust exposure and smoking status in the additive model (OR; CI).

  • CPM, carboxypeptidase M; CPSF6, cleavage and polyadenylation-specific factor 6; MAF, minor allele frequency; SNP, single-neucleotide polymorphism.